Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 20:16:1043-1050.
doi: 10.2147/NDT.S185757. eCollection 2020.

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Murad Atmaca  1
Affiliations
Review

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Murad Atmaca. Neuropsychiatr Dis Treat. .

Abstract

Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.

Keywords: SSRI; current perspectives; sexual dysfunction.

PubMed Disclaimer

Conflict of interest statement

The author reports no conflicts of interest in this work.

References

    1. Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Health Patient Saf. 2010;2:141–150. doi:10.2147/DHPS.S7634 - DOI - PMC - PubMed
    1. Werner FM, Covenas R. Therapeutic effect of novel antidepressant drugs acting at specific receptors of neurotransmitters and neuropeptides. Curr Pharm Des. 2019;25(4):388–395. doi:10.2174/1381612825666190410165243 - DOI - PubMed
    1. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58(1):19–36. doi:10.1016/S0165-0327(99)00092-0 - DOI - PubMed
    1. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995;56(Suppl 6):S12–S21. - PubMed
    1. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19(1):67–85. doi:10.1097/00004714-199902000-00013 - DOI - PubMed